WHI Ireland has a sum-of-the-parts valuation for the shares of 162p - a 40% premium to the current price
WH Ireland applauded the progress of () investee company (NASDAQ: PDSB), which has unveiled plans to raise US$45mln.
The broker said the latest funding round underlined investor confidence in the prospects for PDS and interest in its immuno-oncology platform, Versamune.
NetScientific, an investor in nascent life sciences and technology companies, has supported raises at US$1.30, US$2.75 and now US$8.50 a share (with its planned US$510,000 investment). It has a 5.7% stake in PDS valued at £8.3mln.
WHI, meanwhile, reckons NetScientific is worth significantly more than the current 116p share price. The company’s broker has a sum-of-the-parts valuation of 162p.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...
FOR OUR FULL DISCLAIMER CLICK HERE